By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


LigoCyte Pharmaceuticals, Inc. 

920 Technology Boulevard, Suite C

Bozeman  Montana  59718  U.S.A.
Phone: 406-585-2733 Fax: 406-585-2766



Drug Discovery

Company News
Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Pays $60 Million for LigoCyte Pharmaceuticals, Inc. 10/5/2012 7:46:37 AM
The New England Journal of Medicine Publishes Study Showing LigoCyte Pharmaceuticals, Inc.'s Norovirus Vaccine Demonstrates Protection Against Illness 12/8/2011 10:07:28 AM
LigoCyte Pharmaceuticals, Inc. Looks to Build Manufacturing Facility in Bozeman; Could Potentially Bring Hundreds of Jobs Over the Next Couple of Years 3/30/2011 7:34:15 AM
Positive Results From LigoCyte Pharmaceuticals, Inc.'s Norovirus Vaccine Challenge Study 10/25/2010 6:50:47 AM
LigoCyte Pharmaceuticals, Inc. Initiates First Clinical Trial for Bivalent Intramuscular Norovirus Vaccine 9/16/2010 11:46:14 AM
Data From LigoCyte Pharmaceuticals, Inc.'s Clinical Studies of Norovirus VLP Vaccine Presented at 13th Annual Conference on Vaccine Research 4/28/2010 12:11:28 PM
LigoCyte Pharmaceuticals, Inc. Initiates a Randomized, Double Blind, Placebo Controlled Norovirus Vaccine Study Including Live Virus Challenge 9/8/2009 7:51:22 AM
PacificGMP and LigoCyte Pharmaceuticals, Inc. Announce cGMP Manufacturing Collaboration 2/9/2009 11:03:00 AM
LigoCyte Pharmaceuticals, Inc. Finalizes Agreement for $28M Series 'C' Financing Round 3/18/2008 10:51:36 AM
LigoCyte Pharmaceuticals, Inc. Announces Collaboration With Biogen Idec, Inc. (Massachusetts) (BIIB) to Develop Anti-CD103 Therapies 9/18/2007 7:06:29 AM